Klinik Araştırma

Physical Function And Performance Effects Of Platelet-Rich Plasma (Prp) In Early-Stage Knee Osteoarthritis

Sayı: 1 19 Mart 2026
PDF İndir
TR EN

Physical Function And Performance Effects Of Platelet-Rich Plasma (Prp) In Early-Stage Knee Osteoarthritis

Öz

Aim: Osteoarthritis (OA) is a common, painful and degenerative joint disease that causes functional limitation. Pharmaceutical agents, exercise, physical therapy, intra-articular injections and surgery can be counted among treatment applications. In recent years, platelet-rich plasma (PRP) has been considered as an autologous biological therapy used to stimulate cartilage healing and improve symptoms. Although the effects of PRP injection on pain and function of knee OA patients have been widely investigated before, there have been very limited studies about the effects on physical function and performance. In this study, it was aimed to investigate the effectiveness of PRP in improving physical function and performance in patients with knee OA. Material and Methods: This study was performed with 80 stage 1-2 bilateral knee OA patients according to the Kellgren-Lawrence Scale. Intra-articular PRP injection was applied by the same physician at one month intervals. Physical performances of the patients were analyzed twice, just before the first injection and six months after the last injection, with Stair Climb Test (SCT), 50-Foot Walk Test (50 FWT), 30-second Chair Stand Test (30 CST) and Timed Up and Go Test (TUG). In addition, Hospital for Special Surgery (HSS) knee scoring was also recorded as secondary functional result criteria. Paired-t test was used to assess the significance of the difference in before and after injection results. Results: Statistically significant improvement was observed in all physical performance tests (SCT, 50 FWT, 30 CST, TUG) and functional scoring (HSS) at 6 months after PRP application (p<0.001). Conclusion: PRP is a safe and effective autologous biological agent in improving physical function and performance in patients with mild to moderate knee OA.

Anahtar Kelimeler

Etik Beyan

This study was approved by the Clinical Research Ethics Committee of Balıkesir University Faculty of Medicine. The approval was granted on November 1, 2017, with the decision number 2017/106.

Kaynakça

  1. Görmeli G, Görmeli C.A, Ataoglu B, Çolak C, Aslantürk O, Ertem K. Multiple PRP injections are more effective than single injections and hyaluronicacid in knees with early osteoarthritis: a randomized, double‑blind, placebo‑controlledtrial. KneeSurg Sports TraumatolArthrosc. 2017;25(3):958-965.
  2. Loeser RF, Goldring SR, Scanzello CR, Goldring MB. Osteoarthritis: a disease of the joint as an organ. ArthritisRheum. 2012;64:1697–1707.
  3. Martel-Pelletier J, Barr AJ, Cicuttini FM, Conaghan PG, Cooper C, Goldring MB, Goldring SR, Jones G, Teichtahl AJ, Pelletier JP. Osteoarthritis. Nat Rev Dis Primers. 2016 Oct 13;2:16072. doi: 10.1038/nrdp.2016.72. PMID: 27734845.
  4. Vos T, Flaxman AD, Naghavi M, Lozano R, Michaud C, Ezzati M. Et al. Years lived with disability (YLDs) for 1160 sequelae of 289 diseases and injuries 1990-2010: A systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380:2163–2196.
  5. Maniar KH, Jones IA, Gopalakrishna R,Vangsness JR C.T. Lowering side effects of NSAID usage in osteoarthritis: recent attempts at minimizing dosage. Expert Opınıon On Pharmacotherapy. 2018;19(2): 93-102.
  6. Knights AJ, Redding SJ, Maerz T. Inflammation in osteoarthritis: the latest progress and ongoing challenges. Curr Opin Rheumatol. 2023 Mar 1;35(2):128-134. doi: 10.1097/BOR.0000000000000923. Epub 2022 Dec 22. PMID: 36695054; PMCID: PMC10821795
  7. Dhillon MS, Patel S, Bansal T. Improvising PRP foruse in osteoarthritis knee- upcoming trends and futuristic view. Journal of Clinical Orthopaedics and Trauma 2019;10:32-35.
  8. Filardo G, Kon E, Buda R, Timoncini A, Martino A, Cenacchi A, Fornasari PM, Giannini S, Marcacci M. Platelet-rich plasma intra-articular knee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthrosc 2011;19:528-535.

Ayrıntılar

Birincil Dil

İngilizce

Konular

Ortopedi

Bölüm

Klinik Araştırma

Yayımlanma Tarihi

19 Mart 2026

Gönderilme Tarihi

9 Ağustos 2025

Kabul Tarihi

3 Ocak 2026

Yayımlandığı Sayı

Yıl 2026 Sayı: 1

Kaynak Göster

APA
Atik, A., Arı, B., & Kılıç, A. İ. (2026). Physical Function And Performance Effects Of Platelet-Rich Plasma (Prp) In Early-Stage Knee Osteoarthritis. Medical Records, 1. https://doi.org/10.37990/medr.1752332
AMA
1.Atik A, Arı B, Kılıç Aİ. Physical Function And Performance Effects Of Platelet-Rich Plasma (Prp) In Early-Stage Knee Osteoarthritis. Med Records. 2026;(1). doi:10.37990/medr.1752332
Chicago
Atik, Aziz, Bünyamin Arı, ve Ali İhsan Kılıç. 2026. “Physical Function And Performance Effects Of Platelet-Rich Plasma (Prp) In Early-Stage Knee Osteoarthritis”. Medical Records, sy 1. https://doi.org/10.37990/medr.1752332.
EndNote
Atik A, Arı B, Kılıç Aİ (01 Mart 2026) Physical Function And Performance Effects Of Platelet-Rich Plasma (Prp) In Early-Stage Knee Osteoarthritis. Medical Records 1
IEEE
[1]A. Atik, B. Arı, ve A. İ. Kılıç, “Physical Function And Performance Effects Of Platelet-Rich Plasma (Prp) In Early-Stage Knee Osteoarthritis”, Med Records, sy 1, Mar. 2026, doi: 10.37990/medr.1752332.
ISNAD
Atik, Aziz - Arı, Bünyamin - Kılıç, Ali İhsan. “Physical Function And Performance Effects Of Platelet-Rich Plasma (Prp) In Early-Stage Knee Osteoarthritis”. Medical Records. 1 (01 Mart 2026). https://doi.org/10.37990/medr.1752332.
JAMA
1.Atik A, Arı B, Kılıç Aİ. Physical Function And Performance Effects Of Platelet-Rich Plasma (Prp) In Early-Stage Knee Osteoarthritis. Med Records. 2026. doi:10.37990/medr.1752332.
MLA
Atik, Aziz, vd. “Physical Function And Performance Effects Of Platelet-Rich Plasma (Prp) In Early-Stage Knee Osteoarthritis”. Medical Records, sy 1, Mart 2026, doi:10.37990/medr.1752332.
Vancouver
1.Aziz Atik, Bünyamin Arı, Ali İhsan Kılıç. Physical Function And Performance Effects Of Platelet-Rich Plasma (Prp) In Early-Stage Knee Osteoarthritis. Med Records. 01 Mart 2026;(1). doi:10.37990/medr.1752332